Bayesian meta-analysis of genetic association studies with different sets of markers.

[1]  D. Goldstein,et al.  In vitro assays fail to predict in vivo effects of regulatory polymorphisms. , 2007, Human molecular genetics.

[2]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[3]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[4]  Beverley Balkau,et al.  Variation in FTO contributes to childhood obesity and severe adult obesity , 2007, Nature Genetics.

[5]  N. Gerry,et al.  Open-access database of candidate associations from a genome-wide SNP scan of the Framingham Heart Study , 2007, Nature Genetics.

[6]  John P. A. Ioannidis,et al.  The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities , 2007, Epidemiology.

[7]  J. Ioannidis,et al.  Concordance of functional in vitro data and epidemiological associations in complex disease genetics , 2006, Genetics in Medicine.

[8]  A. Hingorani,et al.  Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk. , 2006, European heart journal.

[9]  A. Hofman,et al.  C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. , 2006, European heart journal.

[10]  David J. Lunn,et al.  A Bayesian toolkit for genetic association studies , 2006, Genetic epidemiology.

[11]  A. Hingorani,et al.  Nature's randomised trials , 2005, The Lancet.

[12]  Olivier Parent,et al.  Bayesian Analysis of Knowledge Spillovers in European Regions , 2005 .

[13]  M. McCarthy,et al.  An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets , 2005, Nature Genetics.

[14]  C. Carlson,et al.  Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. , 2005, American journal of human genetics.

[15]  Claudio J. Verzilli,et al.  A hierarchical Bayesian model for predicting the functional consequences of amino‐acid polymorphisms , 2005 .

[16]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[17]  S. Ebrahim,et al.  Mendelian randomization: prospects, potentials, and limitations. , 2004, International journal of epidemiology.

[18]  Duncan C. Thomas.  Statistical Methods in Genetic Epidemiology , 2004 .

[19]  M. Pepys,et al.  C-reactive protein and cardiovascular disease: new insights from an old molecule. , 2003, QJM : monthly journal of the Association of Physicians.

[20]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[21]  Anne Cambon-Thomsen,et al.  Assessing the impact of biobanks , 2003, Nature Genetics.

[22]  P. McKeigue,et al.  Problems of reporting genetic associations with complex outcomes , 2003, The Lancet.

[23]  S. Ebrahim,et al.  'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.

[24]  C. Weinberg,et al.  Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. , 2002, American journal of epidemiology.

[25]  Christopher Holmes,et al.  Bayesian Methods for Nonlinear Classification and Regressing , 2002 .

[26]  David Clayton,et al.  Epidemiological methods for studying genes and environmental factors in complex diseases , 2001, The Lancet.

[27]  Andrew B. Lawson,et al.  Statistical Methods in Spatial Epidemiology , 2001 .

[28]  L. Cardon,et al.  Association study designs for complex diseases , 2001, Nature Reviews Genetics.

[29]  N. Day,et al.  EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. , 1999, British journal of cancer.

[30]  Giovanni Parmigiani,et al.  Meta-Analysis of Migraine Headache Treatments: Combining Information from Heterogeneous Designs , 1999 .

[31]  S L Normand,et al.  Meta-analysis: formulating, evaluating, combining, and reporting. , 1999, Statistics in medicine.

[32]  N. Day,et al.  Feasibility of heart-rate monitoring to estimate total level and pattern of energy expenditure in a population-based epidemiological study: the Ely young cohort feasibility study 1994–5 , 1997, British Journal of Nutrition.

[33]  Bradley P. Carlin,et al.  BAYES AND EMPIRICAL BAYES METHODS FOR DATA ANALYSIS , 1996, Stat. Comput..

[34]  P. Green.  Reversible jump Markov chain Monte Carlo computation and Bayesian model determination , 1995 .

[35]  J. Besag,et al.  On conditional and intrinsic autoregressions , 1995 .

[36]  J. Besag,et al.  Bayesian image restoration, with two applications in spatial statistics , 1991 .

[37]  D. Berry.  Statistical Methodology in the Pharmaceutical Sciences , 1989 .

[38]  N. Rahman,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2010 .

[39]  Paolo Vineis,et al.  A road map for efficient and reliable human genome epidemiology , 2006, Nature Genetics.

[40]  T. Spector,et al.  Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. , 2004, Clinical chemistry.